Related Experiment Videos

[Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults]

N Aikawa1

  • 1Department of Emergency and Critical Care Medicine, School of Medicine, Keio University, Tokyo, Japan.

Nihon Geka Gakkai Zasshi
|September 1, 1996
PubMed

Insights

Surgical insults trigger a cytokine storm, leading to multiple organ dysfunction syndrome (MODS). New therapies target anti-cytokine and anti-mediator treatments to prevent and treat this critical condition.

Area of Science:

  • Immunology
  • Pathophysiology
  • Critical Care Medicine

Context:

  • Multiple organ dysfunction syndrome (MODS) is a critical condition following major surgery, trauma, burns, or sepsis.
  • The host's inflammatory response to surgical insults is a key factor in developing shock and MODS.
  • Pro-inflammatory cytokines like TNF-alpha and IL-1 beta play a central role in MODS pathogenesis.

Purpose:

  • To elucidate the pathogenetic mechanisms of MODS, focusing on the role of cytokines and inflammatory mediators.
  • To describe the "Cytokine Storm" phenomenon in MODS, characterized by dysregulated cytokine release.
  • To introduce novel therapeutic strategies, including anti-cytokine and anti-mediator therapies for MODS.

Summary:

  • Surgical insults provoke a host response involving macrophages producing TNF-alpha and IL-1 beta, initiating a cascade of inflammatory mediators.
  • Overwhelming insults or secondary insults like sepsis can lead to an exaggerated inflammatory response, termed "Cytokine Storm," causing autodestructive inflammation.
  • This storm involves both pro-inflammatory and anti-inflammatory cytokines, contributing to the systemic dysfunction seen in MODS.

Impact:

  • Understanding the "Cytokine Storm" provides insights into the complex pathophysiology of MODS.
  • Development of targeted anti-cytokine and anti-mediator therapies offers new avenues for preventing and treating life-threatening MODS.
  • This research highlights the potential for immunomodulatory treatments in critical surgical and trauma patients.

Related Concept Videos